England - East Midlands • TMT (technology, media and telecoms)

Potter Clarkson LLP

We only have limited information for this firm. Consider the following firms which have provided more information:

Potter Clarkson LLP’s litigation and licensing team has continued to build on its strong and growing reputation in high-profile, high-value intellectual property disputes and negotiating and drafting IP-centric, agreements across a range of cutting-edge technologies. Working alongside its trade mark and patent attorneys, the team offers full-service capabilities for clients in the life sciences, automotive and FMCG. Litigation and licensing specialist Oliver Laing has built up a following advising investor clients and VC funds on the acquisition of technology-rich businesses, as well as in multi-territorial collaboration and licence agreements. Patent litigators ‘super-intelligent and commercially savvy’ Richard Roberts and Nick McDonald , a ‘great strategist, fantastic on technical detail’ are its key figures. Dave Holt and associate Georgia Carr are also highly recommended.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Potter Clarkson are an excellent team, with particular strength and expertise in patent litigation. Uniquely, they form an incredibly cohesive team between solicitors and patent attorneys to provide a service that is second to none. They have expertise across the board of patent litigation. Their friendly and down-to-earth approach is refreshing and they offer a brilliant service to their clients. The team is a real joy to work with.’

  • ‘Nick McDonald - great strategist, fantastic on technical detail and brilliant with clients.'

Abbreviated data is displayed for this firm.

Key clients

  • Nanexa AB
  • Thelper AS

Abbreviated data is displayed for this firm.

Work highlights

  • Advised Nanexa AB, a Swedish pharmaceutical client, in respect of an infringement claim against competitor, US based VitriVax Inc, relating to Nanexa’s patented enabling technology used to create controlled release of pharmaceutical compositions.
  • Advising Thelper, providing patent prosecution, filing, exploitation and IP strategy advice as well as negotiating commercial research agreements and licences with major pharmaceutical partners relating to its proprietary technology.

Abbreviated data is displayed for this firm.